{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:04:13Z","timestamp":1784707453028,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00066-026-02526-z","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:30:17Z","timestamp":1776781817000},"page":"869-881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Total neoadjuvant therapy with dose-escalated radiotherapy for organ preservation in locally advanced rectal cancer: real-world outcomes"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-9686","authenticated-orcid":false,"given":"O.","family":"Hernando-Requejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0490-6857","authenticated-orcid":false,"given":"M.","family":"L\u00f3pez Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2931-7079","authenticated-orcid":false,"given":"C.","family":"Saiz Guisasola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"S\u00e1nchez Saugar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-0493","authenticated-orcid":false,"given":"A.","family":"Montero Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0130-878X","authenticated-orcid":false,"given":"R.","family":"Ciervide Jurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5118-1513","authenticated-orcid":false,"given":"X.","family":"Chen Zao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2244-801X","authenticated-orcid":false,"given":"B.","family":"\u00c1lvarez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3506-5088","authenticated-orcid":false,"given":"J.","family":"Valero Albarran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garc\u00eda-Aranda Pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Alonso Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4343-7814","authenticated-orcid":false,"given":"C.","family":"Rubio Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"2526_CR1","doi-asserted-by":"crossref","unstructured":"Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a\u00a0comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Vol.\u00a07, The Lancet Gastroenterology and Hepatology. 2022.","DOI":"10.1016\/S2468-1253(21)00426-X"},{"key":"2526_CR2","doi-asserted-by":"crossref","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, et\u00a0al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2017;28.","DOI":"10.1093\/annonc\/mdx224"},{"key":"2526_CR3","doi-asserted-by":"crossref","unstructured":"Nahas SC, Rizkallah Nahas CS, Sparapan Marques CF, Ribeiro U, Cotti GC, Imperiale AR, et\u00a0al. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned from a\u00a0Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer. Dis Colon Rectum. 2016;59(4).","DOI":"10.1097\/DCR.0000000000000558"},{"key":"2526_CR4","doi-asserted-by":"crossref","unstructured":"R\u00f6del C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, et\u00a0al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO\/ARO\/AIO-04 randomised phase\u00a03\u00a0trial. Lancet Oncol. 2012;13(7).","DOI":"10.1016\/S1470-2045(12)70187-0"},{"key":"2526_CR5","doi-asserted-by":"crossref","unstructured":"Ludmir EB, Palta M, Willett CG, Czito BG. Total neoadjuvant therapy for rectal cancer: An emerging option. Vol. 123, Cancer. 2017.","DOI":"10.1002\/cncr.30600"},{"key":"2526_CR6","doi-asserted-by":"crossref","unstructured":"Gabbani M, Giorgi C, Napoli G, Tebano U, Perrone MS, Missiroli S, et\u00a0al. Outcomes of Locally Advanced Rectal Cancer Patients Treated with Total Neoadjuvant Treatment: A\u00a0Meta-Anaysis of Randomized Controlled Trials. Clin Colorectal Cancer. 2022;21(4).","DOI":"10.1016\/j.clcc.2022.07.005"},{"key":"2526_CR7","doi-asserted-by":"crossref","unstructured":"Kasi A, Abbasi S, Handa S, Al-Rajabi R, Saeed A, Baranda J, et\u00a0al. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A\u00a0Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(12).","DOI":"10.1001\/jamanetworkopen.2020.30097"},{"key":"2526_CR8","doi-asserted-by":"crossref","unstructured":"Petrelli F, Trevisan F, Cabiddu M, Sgroi G, Bruschieri L, Rausa E, et\u00a0al. Total Neoadjuvant Therapy in Rectal Cancer: A\u00a0Systematic Review and Meta-analysis of Treatment Outcomes. Vol. 271, Annals of Surgery. 2020.","DOI":"10.1097\/SLA.0000000000003471"},{"key":"2526_CR9","doi-asserted-by":"crossref","unstructured":"Goffredo P, Khan A, Mott SL, Jensen CC, Madoff RD, Gaertner WB, et\u00a0al. Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer: A\u00a0Comparison of Short-and Long-Term Oncologic Outcomes. Ann Surg. 2022;276(6).","DOI":"10.1097\/SLA.0000000000005141"},{"key":"2526_CR10","doi-asserted-by":"crossref","unstructured":"Conroy T, Bosset JF, Etienne PL, Rio E, Fran\u00e7ois \u00c9, Mesgouez-Nebout N, et\u00a0al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a\u00a0multicentre, randomised, open-label, phase\u00a03\u00a0trial. Lancet Oncol. 2021;22(5).","DOI":"10.1016\/S1470-2045(21)00079-6"},{"key":"2526_CR11","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EMK, et\u00a0al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a\u00a0randomised, open-label, phase\u00a03\u00a0trial. Lancet Oncol. 2021;22(1)."},{"key":"2526_CR12","unstructured":"Cise\u0142 B, Pietrzak L, Michalski W, Wyrwicz L, Rutkowski A, Kosakowska E, et\u00a0al. Long-course preoperative chemoradiation versus 5\u00a0\u00d7 5\u202fGy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: Long-term results of the randomized Polish II study. Annals of Oncology. 2019;30(8)."},{"key":"2526_CR13","doi-asserted-by":"crossref","unstructured":"Zhang X, Ma S, Guo Y, Luo Y, Li L. Total neoadjuvant therapy versus standard therapy in locally advanced rectal cancer: A\u00a0systematic review and meta-analysis of 15\u00a0trials. Vol.\u00a017, PLoS ONE. 2022.","DOI":"10.1371\/journal.pone.0276599"},{"key":"2526_CR14","unstructured":"Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, et\u00a0al. Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer: Long-term Results of the CAO\/ARO\/AIO-12 Randomized Clinical Trial. JAMA Oncol. 2022;8(1)."},{"key":"2526_CR15","doi-asserted-by":"crossref","unstructured":"T. Conroy FCPLE et\u00a0al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23\u00a0trial. Annals of Oncology. 2024 Oct;35(10):873\u201381.","DOI":"10.1016\/j.annonc.2024.06.019"},{"key":"2526_CR16","doi-asserted-by":"crossref","unstructured":"Liu S, Jiang T, Xiao L, Yang S, Liu Q, Gao Y, et\u00a0al. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A\u00a0Systematic Review and Meta-Analysis. Oncologist. 2021;26(9).","DOI":"10.1002\/onco.13824"},{"key":"2526_CR17","doi-asserted-by":"crossref","unstructured":"Du R, Chang Y, Zhang J, Cheng Y, Li Y, Zhang C, et\u00a0al. Whether the watch-and-wait strategy has application value for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy? A\u00a0network meta-analysis. Vol.\u00a047, Asian Journal of Surgery. 2024.","DOI":"10.1016\/j.asjsur.2023.11.047"},{"key":"2526_CR18","doi-asserted-by":"crossref","unstructured":"Zhao GH, Deng L, Ye DM, Wang WH, Yan Y, Yu T. Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: A\u00a0meta-analysis. World J Surg Oncol. 2020;18(1).","DOI":"10.1186\/s12957-020-02003-6"},{"key":"2526_CR19","doi-asserted-by":"crossref","unstructured":"Zhang X, Ding R, Li JS, Wu T, Shen ZH, Li SS, et\u00a0al. Efficacy and safety of the \u201cwatch-and-wait\u201d approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a\u00a0meta-analysis. Vol.\u00a036, Surgical Endoscopy. 2022.","DOI":"10.1007\/s00464-021-08932-x"},{"key":"2526_CR20","doi-asserted-by":"crossref","unstructured":"Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva E Sousa AH, et\u00a0al. Operative versus nonoperative treatment for stage\u00a00 distal rectal cancer following chemoradiation therapy: Long-term results. In: Annals of Surgery. 2004.","DOI":"10.1097\/01.sla.0000141194.27992.32"},{"key":"2526_CR21","doi-asserted-by":"crossref","unstructured":"Verheij FS, Omer DM, Williams H, Lin ST, Qin LX, Buckley JT, et\u00a0al. Long-Term Results of Organ Preservation in Patients with Rectal Adenocarcinoma Treated with Total Neoadjuvant Therapy: The Randomized Phase\u00a0II OPRA Trial. In: Journal of Clinical Oncology. 2024.","DOI":"10.1200\/JCO.2023.41.16_suppl.3520"},{"key":"2526_CR22","doi-asserted-by":"crossref","unstructured":"Goffredo P, Quezada-Diaz FF, Garcia-Aguilar J, Smith JJ. Non-Operative Management of Patients with Rectal Cancer: Lessons Learnt from the OPRA Trial. Vol.\u00a014, Cancers. 2022.","DOI":"10.3390\/cancers14133204"},{"key":"2526_CR23","doi-asserted-by":"crossref","unstructured":"Gerard JP, Barbet N, Schiappa R, Magn\u00e9 N, Martel I, Mineur L, et\u00a0al. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x\u2011ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2\u2013cT3 rectal adenocarcinoma (OPERA): a\u00a0phase\u00a03, randomised controlled trial. Lancet Gastroenterol Hepatol. 2023;8(4).","DOI":"10.1016\/S2468-1253(22)00392-2"},{"key":"2526_CR24","doi-asserted-by":"crossref","unstructured":"Fokas E, Glynne-Jones R, Fleischmann M, Piso P, Tselis N, Ghadimi M, et\u00a0al. Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives. Vol. 112, Cancer Treatment Reviews. 2023.","DOI":"10.1016\/j.ctrv.2022.102490"},{"key":"2526_CR25","doi-asserted-by":"crossref","unstructured":"Hearn N, Atwell D, Cahill K, Elks J, Vignarajah D, Lagopoulos J, et\u00a0al. Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a\u00a0Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes. Clin Oncol. 2021;33(1).","DOI":"10.1016\/j.clon.2020.06.008"},{"issue":"2","key":"2526_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/COC.0b013e31826e0703","volume":"37","author":"A Cubillo","year":"2014","unstructured":"Cubillo\u00a0A, Hernando-Requejo\u00a0O, Garc\u00eda-Garc\u00eda\u00a0E, Rodriguez-Pascual\u00a0J, De Vicente\u00a0E, Morelli\u00a0P et\u00a0al (2014) A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancer. American Journal of Clinical Oncology: Cancer Clinical Trials 37(2):117\u2013121","journal-title":"American Journal of Clinical Oncology: Cancer Clinical Trials"},{"issue":"6","key":"2526_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00066-014-0650-0","volume":"190","author":"O Hernando-Requejo","year":"2014","unstructured":"Hernando-Requejo\u00a0O, L\u00f3pez\u00a0M, Cubillo\u00a0A, Rodriguez\u00a0A, Ciervide\u00a0R, Valero\u00a0J et\u00a0al (2014) Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation. Strahlentherapie und Onkologie 190(6):515\u2013520","journal-title":"Strahlentherapie und Onkologie"},{"key":"2526_CR28","doi-asserted-by":"crossref","unstructured":"Safont MJ, Garc\u00eda-Figueiras R, Hernando-Requejo O, Jimenez-Rodriguez R, Lopez-Vicente J, Machado I, et\u00a0al. Interdisciplinary Spanish consensus on a\u00a0watch-and-wait approach for rectal cancer. Clinical and Translational Oncology. 2024;26(4).","DOI":"10.1007\/s12094-023-03322-2"},{"key":"2526_CR29","doi-asserted-by":"crossref","unstructured":"Wang L, Zhang XY, Zhao YM, Li SJ, Li ZW, Sun YS, et\u00a0al. Intentional Watch and Wait or Organ Preservation Surgery Following Neoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-risk Rectal Cancer. Ann Surg. 2023;277(4).","DOI":"10.1097\/SLA.0000000000005507"},{"issue":"4","key":"2526_CR30","first-page":"326","volume":"23","author":"S Bedrikovetski","year":"2024","unstructured":"Bedrikovetski\u00a0S, Traeger\u00a0L, Seow\u00a0W, Dudi-Venkata\u00a0NN (2024) Oncological Outcomes and Response Rate After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A\u00a0Network Meta-Analysis Comparing Induction vs. Consolidation Chemotherapy vs. Standard Chemoradiation. Clin Colorectal Cancer 23(4):326\u2013336","journal-title":"Clin Colorectal Cancer"},{"issue":"9","key":"2526_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bjs\/znaf190","volume":"112","author":"I Prata","year":"2025","unstructured":"Prata\u00a0I, Tanaka\u00a0M, Glimelius\u00a0B, Nagtegaal\u00a0I, Beets-Tan\u00a0R, Blomqvist\u00a0L (2025) Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial. Br J Surg 112(9):112\u2013119","journal-title":"Br J Surg"},{"issue":"5","key":"2526_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.annonc.2025.01.006","volume":"36","author":"H Williams","year":"2025","unstructured":"Williams\u00a0H, FEDMLC, German Rectal Cancer Study Group, OPRA Consortium et\u00a0al (2025) Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO\/ARO\/AIO-12 and OPRA randomized pase II trials. Ann Oncol 36(5):543\u2013547","journal-title":"Ann Oncol"},{"key":"2526_CR33","unstructured":"van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et\u00a0al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. The Lancet. 2018;391(10139)."},{"key":"2526_CR34","doi-asserted-by":"crossref","unstructured":"Thompson HM, Omer DM, Lin S, Kim JK, Yuval JB, Verheij FS, et\u00a0al. Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy. JAMA Netw Open. 2024;7(1).","DOI":"10.1001\/jamanetworkopen.2023.50903"},{"key":"2526_CR35","doi-asserted-by":"crossref","unstructured":"Fernandez LM, S\u00e3o Juli\u00e3o GP, Renehan AG, Beets GL, Papoila AL, Vailati BB, et\u00a0al. The Risk of Distant Metastases in Patients with Clinical Complete Response Managed by Watch and Wait after Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database. Dis Colon Rectum. 2023;66(1).","DOI":"10.1097\/DCR.0000000000002494"},{"key":"2526_CR36","doi-asserted-by":"crossref","unstructured":"Schaap DP, Boogerd LSF, Konishi T, Cunningham C, Ogura A, Garcia-Aguilar J, et\u00a0al. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes. British Journal of Surgery. 2021;108(2).","DOI":"10.1093\/bjs\/znaa009"},{"key":"2526_CR37","doi-asserted-by":"crossref","unstructured":"Kroon HM, Dudi-Venkata NN, Bedrikovetski S, Liu J, Haanappel A, Ogura A, et\u00a0al. Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases. Ann Surg Oncol. 2022;29(2).","DOI":"10.1245\/s10434-021-10762-z"},{"issue":"2","key":"2526_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/DCR.0000000000003586","volume":"68","author":"SH Lai","year":"2024","unstructured":"Lai\u00a0SH, WMMJ\u00a0WMMJ, US Rectal Cancer Research Group et\u00a0al (2024) Rectal Cancer Watch-and-Wait Management: Experience of 545 Patients From the US Rectal Cancer Research Group. Dis Colon Rectum 68(2):180\u2013189","journal-title":"Dis Colon Rectum"},{"key":"2526_CR39","doi-asserted-by":"crossref","unstructured":"Kong JC, Soucisse M, Michael M, Tie J, Ngan SY, Leong T, et\u00a0al. Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A\u00a0Systematic Review and Metaanalysis of Oncological and Operative Outcomes. Vol.\u00a028, Annals of Surgical Oncology. 2021.","DOI":"10.1245\/s10434-021-09837-8"},{"key":"2526_CR40","doi-asserted-by":"crossref","unstructured":"Zaborowski A, Stakelum A, Winter DC. Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer. Vol. 106, British Journal of Surgery. 2019.","DOI":"10.1002\/bjs.11171"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02526-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:55:32Z","timestamp":1784706932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-026-02526-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2526"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02526-z","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.\u00a0Hernando-Requejo, M.\u00a0L\u00f3pez Gonz\u00e1lez, C.\u00a0Saiz Guisasola, E.\u00a0M.\u00a0S\u00e1nchez Saugar, A.\u00a0Montero Luis, R.\u00a0Ciervide Jurio, X.\u00a0Chen Zao, B.\u00a0\u00c1lvarez Rodr\u00edguez, J.\u00a0Valero Albarran, M.\u00a0Garc\u00eda-Aranda Pez, R.\u00a0Alonso Guti\u00e9rrez, and C.\u00a0Rubio Rodr\u00edguez declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional research committee and with the Helsinki declaration, and informed consent was obtained from all individual participants included in this study.","order":2,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}}]}}